Literature DB >> 7892163

Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies.

K Kaji1, Y Nakanuma, M Sasaki, M Unoura, K Kobayashi, A Nonomura, K Tsuneyama, J Van de Water, M E Gershwin.   

Abstract

Interlobular bile ducts are reported to be damaged in viral hepatitis. Such damages are called hepatitic duct injuries and mimic chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. In this study, hepatitic bile duct injuries were evaluated histopathologically and immunohistochemically in 149 needle liver biopsy specimens from patients with chronic hepatitis C and compared immunohistochemically with primary biliary cirrhosis. Fifty-one of the needle biopsies from patients with chronic hepatitis C (34.2%) showed hepatitic bile duct injuries which were distributed focally in the liver and showed variable epithelial damages such as cytoplasmic swelling, vacuolation and acidophilia, nuclear pleomorphism, and loss of nuclear polarity. Some of the injured bile ducts were embedded within lymphoid aggregates, whereas others were surrounded by lymphocytes as well as other inflammatory cells to varied degrees. The majority of lymphoid cells around hepatitic bile duct injury were B- and T-cells mixed in various proportions, and activated T-cells were occasionally found within the biliary epithelial layer. Histopathologic and serial section studies disclosed that bile duct loss was rare in chronic hepatitis C. Statistical analysis revealed that advancement of chronic hepatitis and the degree of necroinflammatory processes of the liver, particularly in the portal tracts, were positively correlated with the occurrence of hepatitic bile duct injuries. Immunohistochemical studies demonstrated that, whereas strong ectopic expression of HLA-DR and enhanced expression of HLA-A,B,C, and pyruvate dehydrogenase E2-complex in biliary epithelial cells were frequently observed in chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis, such unusual expressions were generally absent or mild, even if present, in bile duct injuries in chronic hepatitis C.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892163

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

Review 1.  Hepatitis C virus and allogeneic stem cell transplantation still matters!

Authors:  Gérard Socié; Régis Peffault de Latour; George B McDonald
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

2.  Effect of interferon therapy on bile duct inflammation in hepatitis C.

Authors:  B F Banner; C Allan; L Smith; L Savas; H L Bonkovsky
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Hepatitis C and bile duct loss.

Authors:  R D Goldin; N K Patel; H C Thomas
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 4.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Cholestatic presentation of chronic hepatitis C: a clinical and histological study with a review of the literature.

Authors:  K S Kumar; M H Saboorian; W M Lee
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

6.  Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities.

Authors:  E Lebovics; F Seif; D Kim; A Elhosseiny; B M Dworkin; A Casellas; S Clark; W S Rosenthal
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

7.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Yasuni Nakanuma
Journal:  Hepat Res Treat       Date:  2010-11-04

9.  Chronic hepatitis C and autoimmune cholangitis: a case study and literature review.

Authors:  Pilar Sánchez-Pobre; Carmen Gonzalez; Estela Paz; Francisco Colina; Gregorio Castellano; Teresa Muñoz-Yague; Sarbelio Rodriguez; Carmen Yela; Victoria Alvarez; Ja Solís-Herruzo
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.

Authors:  Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.